Page last updated: 2024-12-07
averufanin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
averufanin: precursor of aflatoxin B1; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 119255 |
| SCHEMBL ID | 15676485 |
| MeSH ID | M0147075 |
Synonyms (8)
| Synonym |
|---|
| averufanin |
| 28458-24-4 |
| 1,3,6,8-tetrahydroxy-2-[(2s,6s)-6-methyloxan-2-yl]anthracene-9,10-dione |
| 9,10-anthracenedione, 1,3,6,8-tetrahydroxy-2-(tetrahydro-6-methyl-2h-pyran-2-yl)-, cis-(+)- (van) |
| 9,10-anthracenedione, 1,3,6,8-tetrahydroxy-2-((2r,6r)-tetrahydro-6-methyl-2h-pyran-2-yl)-, rel-(+)- |
| SCHEMBL15676485 |
| 1,3,6,8-tetrahydroxy-2-(6-methyloxan-2-yl)anthracene-9,10-dione |
| DTXSID60951105 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||